Safety, tolerability and pharmacokinetics of the fibroblast growth factor receptor inhibitor AZD4547 in Japanese patients with advanced solid tumours: a Phase I study
about
Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancer.A Phase 1 study of ARQ 087, an oral pan-FGFR inhibitor in patients with advanced solid tumours.Endometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model.Discovery and Biological Evaluation of a Series of Pyrrolo[2,3-b]pyrazines as Novel FGFR Inhibitors.
P2860
Safety, tolerability and pharmacokinetics of the fibroblast growth factor receptor inhibitor AZD4547 in Japanese patients with advanced solid tumours: a Phase I study
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Safety, tolerability and pharm ...... solid tumours: a Phase I study
@ast
Safety, tolerability and pharm ...... solid tumours: a Phase I study
@en
type
label
Safety, tolerability and pharm ...... solid tumours: a Phase I study
@ast
Safety, tolerability and pharm ...... solid tumours: a Phase I study
@en
prefLabel
Safety, tolerability and pharm ...... solid tumours: a Phase I study
@ast
Safety, tolerability and pharm ...... solid tumours: a Phase I study
@en
P2093
P2860
P1476
Safety, tolerability and pharm ...... solid tumours: a Phase I study
@en
P2093
Catherine Tchinou
Chiyoe Kitagawa
Hideo Saka
Koshi Fujikawa
Naoki Takahashi
Satoru Iwasa
Tamotsu Sagawa
Taro Fukao
Yasuhide Yamada
Yasuo Takahashi
P2860
P2888
P304
P356
10.1007/S10637-016-0416-X
P577
2017-01-10T00:00:00Z
P6179
1038272847